Transfusion-associated graft-versus-host disease in immunocompetent patients: Case series and review of the literature

Transfusion

Volumn 47, Issue 8, 2007, Pages 1405-1411

  Agbaht, Kemal ^a   Altintas, Neriman Defne ^b   Topeli, Arzu ^b   Gokoz, Ozay ^b   Ozcebe, Osman ^b  

^a HACETTEPE UNIVERSITY   (Turkey)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN; LYMPHOCYTE ANTIBODY; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; THYMOCYTE ANTIBODY;

ADULT; AGED; ARTICLE; BLOOD RADIATION; BONE MARROW BIOPSY; CASE REPORT; CASE STUDY; DISEASE ASSOCIATION; FEMALE; GRAFT VERSUS HOST REACTION; HLA TYPING; HUMAN; IMMUNOCOMPROMISED PATIENT; MALE; SKIN BIOPSY;

ADULT; AGED; BLOOD TRANSFUSION; FEMALE; GRAFT VS HOST DISEASE; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED;

EID: 34547095743     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2007.01282.x     Document Type: Article

References (37)

1. Schroeder ML. Transfusion-associated graft-versus-host disease. Br J Haematol 2002 117 : 275 87.
2. Anderson KC, Weinstein HJ. Transfusion-associated graft-versus-host disease. N Engl J Med 1990 323 : 315 21.
3. Greenbaum BH. Transfusion-associated graft-versus-host disease: historical perspectives, incidence, and current use of irradiated blood products. J Clin Oncol 1991 9 : 1889 902.
4. von Fliedner V, Higby DJ, Kim U. Graft-versus-host reaction following blood product transfusion. Am J Med 1982 72 : 951 61.
5. Burns LJ, Westberg MW, Burns CP, et al. Acute graft-versus-host disease resulting from normal donor blood transfusions. Acta Haematol 1984 71 : 270 6.
6. Ohto H, Anderson KC. Survey of transfusion-associated graft-versus-host disease in immunocompetent recipients. Transfus Med Rev 1996 10 : 31 43.
7. Arsura EL, Bertelle A, Minkowitz S, Cunningham JN Jr., Grob D. Transfusion-associated-graft-vs-host disease in a presumed immunocompetent patient. Arch Intern Med 1988 148 : 1941 4.
8. Serefhanoglu K, Turan H, Saba T, et al. Transfusion-associated graft-versus-host disease in an immunocompetent individual following cardiac surgery. J Natl Med Assoc 2005 97 : 418 20.
9. Aoun E, Shamseddine A, Chehal A, Obeid M, Taher A. Transfusion-associated GVHD: 10 years' experience at the American University of Beirut-Medical Center. Transfusion 2003 43 : 1672 6.
10. Petz LD, Calhoun L, Yam P, et al. Transfusion-associated graft-versus-host disease in immunocompetent patients: report of a fatal case associated with transfusion of blood from a second-degree relative, and a survey of predisposing factors. Transfusion 1993 33 : 742 50.
11. Triulzi D, Duquesnoy R, Nichols L, et al. Fatal transfusion-associated graft-versus-host disease in an immunocompetent recipient of a volunteer unit of red cells. Transfusion 2006 46 : 885 8.
12. Perrotta PL, Snyder EL. Non-infectious complications of transfusion therapy. Blood Rev 2001 15 : 69 83.
13. Klein HG. Transfusion-associated graft-versus-host disease: less fresh blood and more gray (Gy) for an aging population. Transfusion 2006 46 : 878 80.
14. Guinan EC, Shimomura A. Acquired and inherited aplastic anemia syndromes. In : Greer JP, Rodgers GM, Foerster J, et al., editors. Wintrobe's clinical hematology. 11th ed. Philadelphia : Lippincott Williams & Wilkins Press 2004. p. 1402 3.
15. McMilin KD, Johnson RL. HLA homozygosity and the risk of related-donor transfusion-associated graft-versus-host disease. Transfus Med Rev 1993 7 : 37 41.
16. Sage D, Stanworth S, Turner D, Navarrete C. Diagnosis of transfusion-associated graft-vs.-host disease: the importance of short tandem repeat analysis. Transfus Med 2005 15 : 481 5.
17. Lerner KG, Kao GF, Storb R, et al. Histopathology of graft-vs.-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors. Transplant Proc 1974 6 : 367 71.
18. Marra DE, McKee PH, Nghiem P. Tissue eosinophils and the perils of using skin biopsy specimens to distinguish between drug hypersensitivity and cutaneous graft-versus-host disease. J Am Acad Dermatol 2004 51 : 543 6.
19. Oto OA, Paydas S, Baslamisli F, et al. Transfusion-associated graft-versus-host disease. Eur J Intern Med 2006 17 : 151 6.
20. Asai T, Inaba S, Ohto H, et al. Guidelines for irradiation of blood and blood components to prevent post-transfusion graft-vs.-host disease in Japan. Transfus Med 2000 10 : 315 20.
21. Pelszynski MM, Moroff G, Luban NL, Taylor BJ, Quinones RR. Effect of gamma irradiation of red blood cell units on T-cell inactivation as assessed by limiting dilution analysis: implications for preventing transfusion-associated graft-versus-host disease. Blood 1994 83 : 1683 9.
22. Moroff G, Luban NL. The irradiation of blood and blood components to prevent graft-versus-host disease: technical issues and guidelines. Transfus Med Rev 1997 11 : 15 26.
23. Grass JA, Wafa T, Reames A, et al. Prevention of transfusion-associated graft-versus-host disease by photochemical treatment. Blood 1999 93 : 3140 7.
24. Luban NL. Prevention of transfusion-associated graft-versus-host disease by inactivation of T cells in platelet components. Semin Hematol 2001 38 : 34 45.
25. Pineda A, McCullough J, Benjamin RJ, et al. Pathogen inactivation of platelets with a photochemical treatment with amotosalen hcl and ultraviolet light: process used in the sprint trial. Transfusion 2006 46 : 562 71.
26. Wagner SJ, Skripchenko A, Robinette D, et al. The use of dimethylmethylene blue for virus photoinactivation of red cell suspensions. Dev Biol (Basel) 2000 102 : 125 9.
27. Falagas ME, Apostolou KE, Pappas VD. Attributable mortality of candidemia: a systematic review of matched cohort and case-control studies. Eur J Clin Microbiol Infect Dis 2006 25 : 419 25.
28. Alexander JW, Boyce ST, Babcock GF, et al. The process of microbial translocation. Ann Surg 1990 212 : 496 510 discussion 511 492.
29. Hutchinson K, Kopko PM, Muto KN, et al. Early diagnosis and successful treatment of a patient with transfusion-associated GVHD with autologous peripheral blood progenitor cell transplantation. Transfusion 2002 42 : 1567 72.
30. Yasukawa M, Shinozaki F, Hato T, et al. Successful treatment of transfusion-associated graft-versus-host disease. Br J Haematol 1994 86 : 831 6.
31. Mori S, Matsushita H, Ozaki K, et al. Spontaneous resolution of transfusion-associated graft-versus-host disease. Transfusion 1995 35 : 431 5.
32. Ryo R, Saigo K, Hashimoto M, et al. Treatment of post-transfusion graft-versus-host disease with nafmostat mesilate, a serine protease inhibitor. Vox Sang 1999 76 : 241 6.
33. Nishimura M, Hidaka N, Akaza T, Tadokoro K, Juji T. Immunosuppressive effects of chloroquine: potential effectiveness for treatment of post-transfusion graft-versus-host disease. Transfus Med 1998 8 : 209 14.
34. Anwar M, Bhatti FA. Transfusion associated graft versus host disease. J Ayub Med Coll Abbottabad 2003 15 : 56 8.
35. Janatpour K, Denning L, Nelson K, et al. Comparison of x-ray vs. gamma irradiation of CPDA-1 red cells. Vox Sang 2005 89 : 215 9.
36. Herva E, Kiviniity K. The effect of in vitro irradiation on the responses of human lymphocytes to PHA, PPD and allogeneic cells. Strahlentherapie 1975 149 : 504 12.
37. Sowemimo-Coker SO. Red blood cell hemolysis during processing. Transfus Med Rev 2002 16 : 46 60.